Association of selected antipsychotics on the triglyceride levels in patients with schizophrenia in inpatient and outpatient settings
Clinical Neuropsychopharmacology and Therapeutics · 2020
DOI: 10.5234/cnpt.11.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Therapeutics, 2020. Verfasst von Shin Ono und 12 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ono, S., Sugai, T., Suzuki, Y., Yamazaki, M., Shimoda, K., Mori, T., Ozeki, Y., Matsuda, H., Sugawara, N., Yasui-Furukori, N., Okamoto, K., Sagae, T., & Someya, T. (2020). Association of selected antipsychotics on the triglyceride levels in patients with schizophrenia in inpatient and outpatient settings. Clinical Neuropsychopharmacology and Therapeutics. https://doi.org/10.5234/cnpt.11.15
Vancouver
Ono S, Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, et al. Association of selected antipsychotics on the triglyceride levels in patients with schizophrenia in inpatient and outpatient settings. Clinical Neuropsychopharmacology and Therapeutics. 2020. doi:10.5234/cnpt.11.15
BibTeX
@article{Ono2020,
author = {Ono, Shin and Sugai, Takuro and Suzuki, Yutaro and Yamazaki, Manabu and Shimoda, Kazutaka and Mori, Takao and Ozeki, Yuji and Matsuda, Hiroshi and Sugawara, Norio and Yasui-Furukori, Norio and Okamoto, Kurefu and Sagae, Toyoaki and Someya, Toshiyuki},
title = {Association of selected antipsychotics on the triglyceride levels in patients with schizophrenia in inpatient and outpatient settings},
journal = {Clinical Neuropsychopharmacology and Therapeutics},
year = {2020},
doi = {10.5234/cnpt.11.15}
}
EUVIMED